Professor Ray Borrow
|Ray Borrow is Head of the Vaccine Evaluation Unit at Public Health England (formerly Health Protection Agency), Manchester, UK, where he is responsible for the evaluation of serological responses to various bacterial and viral vaccines with a special interest in meningococcal and pneumococcal vaccines. He gained his PhD in 1994, his MRCPath in 2003 and he became a Professor of Vaccine Preventable Diseases in the Faculty of Medical and Human Sciences at the University of Manchester in 2009 and Visiting Professor at the School of Healthcare Sciences, Manchester Metropolitan University in 2011. His scientific findings resulted in over 240 peer reviewed published papers. Until recently he served as a member of the DoH Joint Committee of Vaccination and Immunisation (JCVI) and continues to date as an expert advisor. He is an ad hoc advisor to WHO on both meningococcal and pneumococcal vaccines. He chairs our scientific advisory panel.|
Professor Adam Finn
|Adam Finn is Professor of Paediatrics and a member of the Schools of Clinical Sciences and of Cellular and Molecular Medicine at the University of Bristol and an honorary Consultant in Paediatric Infectious diseases and Immunology at Bristol Royal Hospital for Children. He is director of the South West Medicines for Children Research Network and heads the Bristol Children's Vaccine Centre. He trained in Infectious Diseases at the Children's Hospital of Philadelphia and in Immunology at the Institute of Child Health in London where he obtained his PhD. |
He worked in Sheffield between 1992 and 2001 where he was involved in several trials of meningococcal group C and other vaccines. His current main research interest is the biology of respiratory infections and how vaccines affect transmission of infections.
Professor Paul Heath
|Paul Heath is a Professor / Honorary Consultant in Paediatric Infectious Diseases at St George’s, University of London and Vaccine Institute in London. His training in paediatrics and infectious diseases was at the Royal Children’s Hospital, Melbourne, the John Radcliffe Hospital, Oxford and St George’s Hospital, London. His particular research interests are in the epidemiology of vaccine preventable diseases, in clinical vaccine trials, particularly in at-risk groups, and in perinatal infections. He coordinates a national neonatal infection surveillance network (neonIN) and recently, a national study on neonatal meningitis. He sits on national committees concerned with meningitis, Group B streptococcus prevention, Pneumococcal and Hib infections, neonatal infections and on immunisation policies in children. He is a Fellow of the Royal Australasian College of Physicians, a Fellow of the Royal College of Paediatrics and Child Health, a member of the research committee of the European Society of Paediatric Infectious Diseases and a member of the steering committee of the international Brighton Collaboration on vaccine safety.|
Professor Nigel Klein
|Nigel Klein is Professor and Consultant in Paediatric Infectious Diseases and Immunology at Great Ormond Street Children’s Hospital, London, and the Institute of Child Health, University College London. He trained at UCL, obtaining degrees in Anatomy and in Medicine. He worked in the three London centres specialising in Paediatric Infectious Diseases before completing his formal training at ICH/GOSH. He is currently Head of Infectious Diseases Unit at ICH and was Head of the Department of Infection at UCL until 2008. He has been working in the fields of Meningitis and Sepsis for many years, in both a clinical and academic capacity. Nigel is a scientific advisor for a number of medical research charities.|
Professor Michael Levin
| Michael Levin is Professor of Paediatrics and International Child Health, and Director of the Wellcome Centre for Tropical Clinical Medicine at Imperial College London. He trained in medicine in South Africa and in paediatrics in the UK before specialising in infectious diseases. His research has focused on life threatening infections of childhood. He currently heads an international EU-funded consortium studying novel diagnostic methods for tuberculosis in Africa working with colleagues in Malawi and South Africa. He recently led an ESPID funded consortium studying the genetic basis of meningococcal disease, and is a co-investigator on the MRC funded Phase III trial of fluids as supportive treatment for critical illness in African children (“FEAST”), the results of which are recently published in the New England Journal of Medicine. He is the co-ordinator of a recently funded European Commission FP7 award studying the genetic basis of meningococcal and other life threatening bacterial infections of childhood, working with a consortium of colleagues from Europe, Africa and Singapore.|
Professor Michael Levin
Professor Michael Levin
Dr Fiona McGill
Professor Michael Levin
Professor Michael Levin
|Fiona McGill graduated from medical school at the University of Aberdeen in 2000. She moved south of the border one year later to take up a medical rotation in Middlesbrough. After 2 and half years there she pursued her interest in Infectious Diseases and took up a clinical fellow post in Newcastle-Upon Tyne. |
After a year in New Zealand and the diploma in tropical medicine she moved back to Newcastle-Upon-Tyne where she started her specialist registrar training in Infectious Diseases. Within the year she obtained a training number in the Yorkshire and The Humber region in infectious diseases and microbiology.
Since April 2011 she has taken some time out of clinical duties to work as a Clinical Research Fellow in the Liverpool Brain Infections Group with Prof Tom Solomon and his team working on an epidemiological study on viral meningitis in the UK and funded by us.
Mr Fergal Monsell
|Fergal Monsell has been a Consultant Paediatric Orthopaedic Surgeon at the Royal Hospital for Children, Bristol since 2005. He worked in the same capacity at The Hospital for Sick Children, Great Ormond Street and The Royal National Orthopaedic Hospital, Stanmore between 1997 and 2005. |
He completed his higher surgical training at the University of Manchester and fellowship training at the Royal Alexandra Hospital for Children, Sydney, Australia.
He has a broad based practice with a special interest in limb reconstruction surgery using a spectrum of contemporary techniques. He has considerable experience in the management of patients with the skeletal consequences of septicaemia and contributes to a multi-disciplinary team specifically managing this patient group. He is active in all aspects of paediatric trauma and has published on this subject.
He has an active clinical and basic science research portfolio and received a Doctorate of Philosophy in 2010, defending a thesis that explored the effect of chemotherapy on regenerate bone formation in distraction osteogenesis.
Dr Simon Nadel
|Simon Nadel has been a Consultant in Paediatric Intensive Care since 1994. Prior to this he trained in paediatric infectious diseases. He has been involved in coordinating and running therapeutic trials in children with meningococcal and other septic shock, and has taken part in research studies into the pathophysiology, treatment and outcome of meningococcal disease in children. He has been involved in writing clinical guidelines for the management of children with septicaemia and meningitis.|
Dr Ifeanyichukwu Okike
|Ifeanyichukwu Okike is a Clinical Research Fellow at St George’s, University of London. He is responsible for coordinating the MRF-funded bacterial meningitis in infants < 90 days of age: burden of disease and assessment of healthcare delivery study (neoMen). Both studies have been collaboration with the British Paediatric Surveillance Unit (BPSU) and Public Health England (PHE).|
Dr Okike obtained his medical degree from Uludag University in Bursa, Turkey and did his Internship in Turkey and University Hospital Leuven, Belgium before starting his training in Paediatrics in the UK.
The neoMen study and other population based studies will also help put meningitis in the first three months of life into context at a population level. These projects form part of Okike’s PhD with St George’s, University of London and also part of his Specialist Registrar training in Paediatrics.
Dr Nelly Ninis
|Nelly Ninis is currently a consultant in General Paediatrics at St Mary’s Hospital, Paddington. She has completed training in paediatric infectious diseases and immunology and has an MSc in tropical medicine. She worked for three years on the Paediatric Intensive Care Unit at St Mary’s when it was a specialist referral unit for meningococcal sepsis.|
She conducted the RCPCH study on healthcare delivery and the outcome of meningococcal disease in children, funded by MRF. From this study she has developed an interest in the way sepsis is diagnosed both in primary and secondary care.
Dr Ninis is also a part of the National Institute for Health and Clinical Excellence (NICE) Guideline Development Group for Meningitis and Septicaemia.
Dr Nelly Ninis
Dr Andrew Riordan
|Andrew Riordan is Consultant in Paediatric Infectious Diseases and Immunology at Alder Hey Children's NHS Foundation Trust, Liverpool, UK. |
He was Johanne Holly Research Fellow at the University of Liverpool and wrote his Doctoral Thesis on Meningococcal Disease. He has helped produce NICE guidance, standards for the care of children with HIV and advice to the Joint Committee on Vaccination and Immunisation.
Dr Matthew Snape
|Matthew Snape is a consultant in General Paediatrics and Vaccinology at the Oxford University Hospitals NHS trust and an Honorary Senior Clinical Lecturer at the University of Oxford.|
Dr Snape trained at the Royal Children's Hospital, Melbourne, and at St Mary's Hospital, London. While caring for children suffering overwhelming infections on the St Mary’s paediatric intensive care unit he developed an interest in the prevention of these illnesses by immunisation.
To this end he has worked at the Oxford Vaccine Group (University of Oxford) since 2003, conducting research related to vaccines against meningococcal, pneumococcal, group B streptococcus, influenza and hepatitis B disease. Of particular importance has been the ongoing involvement with the development of the vaccines against serogroup B meningococcus. He continues to be an investigator on vaccine clinical trials while working as a general paediatrician at the Children’s Hospital, Oxford.
Dr Snape is partially funded by the NIHR Oxford Biomedical Research Centre.
Dr Alistair Thomson
|Alistair Thomson trained at Cambridge, King's College Hospital London, St Thomas’ Hospital and Alder Hey Children’s Hospital in Liverpool. Since 1990 he has been Consultant Paediatrician at Mid Cheshire Hospitals NHS Trust. He has co-led a rolling research programme into meningococcal disease on Merseyside. He has published extensively, on subjects ranging from the pathophysiology of meningococcal infection, it is treatment and outcome, to the importance of accurate publicity in the disease. He has been a member of the National Institute of Clinical Excellence (NICE) Guidelines and Topic Expert Groups on Bacterial Meningitis and Meningococcal Disease.|
Dr Matthew Thompson
|Matthew Thompson is a Clinical Lecturer in General Practice at the University of Oxford Department of Primary Health Care and a General Practitioner in Cowley, Oxford. He received his medical degree from the University of Glasgow, postgraduate training in general practice in the UK, family medicine residency training at the University of Cincinnati, Primary Care Research Fellowship and Masters in Public Health at the University of Washington, and has recently submitted his DPhil titled “Predicting serious bacterial infections in children in primary care” at the University of Oxford. He has worked as a family doctor in South Africa, USA, and the UK. His research currently focuses on paediatric infections in primary care, including a study of presenting features of meningococcal disease in primary care, a cohort study of children attending a paediatric assessment unit, a survey of the clinical techniques GPs use to assess children with acute infection, and a cross sectional study of children with self-limiting infections to determine the reference ranges for heart rate in children with fever. He is currently the recipient of a grant from the MRF to conduct a survey of presenting symptoms in children in primary care.|